Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lasoperin is a patented, natural cognitive aid developed by Unigen, Inc., consisting of a standardized bioflavonoid composition derived from botanical sources. It is designed to support brain health, attention, focus, and memory through a dual mechanism of action: providing potent antioxidant activity to neutralize free radicals and modulating the cyclooxygenase (COX) and lipoxygenase (LOX) pathways to maintain a healthy inflammatory response. Clinical data suggests that Lasoperin provides both short-term nutritional support for mental clarity and long-term neuroprotection against oxidative stress-induced cognitive decline. It is primarily intended for use as an ingredient in dietary supplements.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lasoperin.